Atlas Trials

Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65

Clinical trial NCT01208662 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT01208662
Sponsor
Paul Richardson, MD
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2010-09-01
Primary completion
2022-02-01
Enrollment
729

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.